Technology areas: Biotechnology & Pharmaceuticals • Transportation, E-Commerce & Mechanical Systems
27 pending office actions • 20 art units • 27 examiners • 0 of 27 (0%) have an AI response strategy ready • 24 patents granted in the last 365 days
Idexx Laboratories Inc. has 26 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 26 examiners and 18 art units, indicating broad examiner distribution across a portfolio that remains concentrated in one technology area.
REYES, REGINALD R is the listed busiest examiner, with 1 pending matter. The supplied figures do not identify a dominant examiner concentration, so docket management should emphasize consistent technical positions and claim strategy across separate examiner relationships.
The difference between examiner and art-unit coverage indicates that some art units handle more than one matter, while every listed examiner handles a single pending matter. That pattern supports centralized monitoring of recurring disclosure and claim issues, combined with examiner-specific response planning.
For prosecution counsel, the portfolio calls for coordination across many individual office-action records rather than reliance on one established examiner dialogue. Tracking amendments, cited art, and unresolved positions by art unit can help preserve consistency while accommodating the distinct examination settings.
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 2 (7%) |
| §101 + other | 8 (30%) |
| §103 only | 4 (15%) |
| Double-patenting only | 1 (4%) |
| Multi-statute (no §101) | 12 (44%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| REYES, REGINALD R | 1 | 40.9% | +31.5% |
| RIZVI, AKBAR HASSAN | 1 | 88.1% | +14.9% |
| DABBI, JYOTSNA V | 1 | 62.5% | +23.3% |
| SHIN, SOO JUNG | 1 | 87.2% | +16.1% |
| WILLIAMS, TERESA S | 1 | 25.1% | +17.2% |
| PLAYER, ROBERT AUSTIN | 1 | 13.6% | +34.1% |
| KIDWELL, KAITLYN ELIZABETH | 1 | 76.5% | +22.6% |
| MCNICHOLS, ERET C | 1 | 75.0% | -15.6% |
| SHIMELES, BEZAWIT NOLAWI | 1 | 90.0% | +0.0% |
| BUDISALICH, ANDREW STEVEN | 1 | 79.1% | +4.0% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18985324 | FLOW CYTOMETER AND LASER OPTICS ASSEMBLY THEREOF | RIZVI, AKBAR HASSAN | — |
| 18968256 | Methods and Systems for X-Ray Imaging and Labeling | SHIN, SOO JUNG | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18757823 | Methods and Systems for In-Clinic Compliance Protocols | PAULS, JOHN A | 30d overdue |
| 18222429 | Determination of Hematocrit | MISHRA, DEEPA | 20d |
| 19009409 | MACHINE LEARNING MODELS FOR ADDISON'S DISEASE RISK ANALYSIS | REYES, REGINALD R | 28d |
| 18541764 | DEVICES AND METHODS FOR DETECTING PANCREATIC LIPASE | DAVIS, RUTH A | 70d |
| 18977033 | PROCESS AND SYSTEMS FOR AUTOFOCUSING AND MEASURING TILT OF SAMPLE PLANE | DABBI, JYOTSNA V | — |
| 18968352 | DIGITAL MICROSCOPY DATA VISUALIZATION SYSTEMS AND METHODS FOR USING THE SAME | WILLIAMS, TERESA S | — |
| 18968694 | Methods, Systems, and Devices for Hematologic Morphology Detection and Treatment | PLAYER, ROBERT AUSTIN | — |
| 18961590 | IMAGING WHITE BLOOD CELLS IN PRESENCE OF RED BLOOD CELLS | KIDWELL, KAITLYN ELIZABETH | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19009409 | MACHINE LEARNING MODELS FOR ADDISON'S DISEASE RISK ANALYSIS | REYES, REGINALD R | 28d |
| 18985324 | FLOW CYTOMETER AND LASER OPTICS ASSEMBLY THEREOF | RIZVI, AKBAR HASSAN | — |
| 18977033 | PROCESS AND SYSTEMS FOR AUTOFOCUSING AND MEASURING TILT OF SAMPLE PLANE | DABBI, JYOTSNA V | — |
| 18968256 | Methods and Systems for X-Ray Imaging and Labeling | SHIN, SOO JUNG | — |
| 18968352 | DIGITAL MICROSCOPY DATA VISUALIZATION SYSTEMS AND METHODS FOR USING THE SAME | WILLIAMS, TERESA S | — |
| 18968694 | Methods, Systems, and Devices for Hematologic Morphology Detection and Treatment | PLAYER, ROBERT AUSTIN | — |
| 18961590 | IMAGING WHITE BLOOD CELLS IN PRESENCE OF RED BLOOD CELLS | KIDWELL, KAITLYN ELIZABETH | — |
| Art Unit | Apps |
|---|---|
| 3684 | 3 |
| 2877 | 2 |
| 2667 | 2 |
| 1798 | 2 |
| 1678 | 2 |
| 2872 | 1 |
| 3687 | 1 |
| 1686 | 1 |
| 3632 | 1 |
| 2673 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19009409 | MACHINE LEARNING MODELS FOR ADDISON'S DISEASE RISK ANALYSIS | REYES, REGINALD R | 3684 | §101 | Final Rejection | 28d | Pending | Jan 03, 2025 |
| 18985324 | FLOW CYTOMETER AND LASER OPTICS ASSEMBLY THEREOF | RIZVI, AKBAR HASSAN | 2877 | §103Other | Final Rejection | — | Pending | Dec 18, 2024 |
| 18977033 | PROCESS AND SYSTEMS FOR AUTOFOCUSING AND MEASURING TILT OF SAMPLE PLANE | DABBI, JYOTSNA V | 2872 | §102§103 | Non-Final OA | — | Pending | Dec 11, 2024 |
| 18968256 | Methods and Systems for X-Ray Imaging and Labeling | SHIN, SOO JUNG | 2667 | DP | Non-Final OA | — | Pending | Dec 04, 2024 |
| 18968352 | DIGITAL MICROSCOPY DATA VISUALIZATION SYSTEMS AND METHODS FOR USING THE SAME | WILLIAMS, TERESA S | 3687 | §101§102§103 | Non-Final OA | — | Pending | Dec 04, 2024 |
| 18968694 | Methods, Systems, and Devices for Hematologic Morphology Detection and Treatment | PLAYER, ROBERT AUSTIN | 1686 | §101§103 | Non-Final OA | — | Pending | Dec 04, 2024 |
| 18961590 | IMAGING WHITE BLOOD CELLS IN PRESENCE OF RED BLOOD CELLS | KIDWELL, KAITLYN ELIZABETH | 2877 | §102§103 | Final Rejection | — | Pending | Nov 27, 2024 |
| 18962899 | Devices and Methods for Alignment Tools | MCNICHOLS, ERET C | 3632 | §102§103§112 | Non-Final OA | — | Pending | Nov 27, 2024 |
| 18961571 | QUANTIFYING CONSTITUENTS IN A SAMPLE CHAMBER USING IMAGES OF DEPTH REGIONS | SHIMELES, BEZAWIT NOLAWI | 2673 | §101§103 | Non-Final OA | — | Pending | Nov 27, 2024 |
| 18961545 | QUANTIFYING CONSTITUENTS IN A SAMPLE CHAMBER USING IMAGES OF DEPTH REGIONS | BUDISALICH, ANDREW STEVEN | 2662 | §101§103 | Non-Final OA | — | Pending | Nov 27, 2024 |
| 18961614 | IDENTIFYING LARGER OBJECTS IN EAR CONTENT SAMPLES | HWANG, JINSU | 2667 | §101§102 | Non-Final OA | — | Pending | Nov 27, 2024 |
| 18910810 | Methods, Devices, Kits and Compositions for Detecting Tapeworm | GRASER, JENNIFER E | — | §103§112 | Non-Final OA | — | Pending | Oct 09, 2024 |
| 18807045 | HYBRID MACHINE LEARNING MODELS FOR IMPROVED DIAGNOSTIC ANALYSIS | CHOI, DAVID | 3684 | §101§103 | Non-Final OA | — | Pending | Aug 16, 2024 |
| 18757823 | Methods and Systems for In-Clinic Compliance Protocols | PAULS, JOHN A | 3683 | §101 | Non-Final OA | 30d overdue | Pending | Jun 28, 2024 |
| 18627865 | Methods and Systems for Remote Installation of Computer Software and Monitoring Progress of the Installation on a Local Computing Entity | SOLTANZADEH, AMIR | 2191 | §103 | Non-Final OA | — | Pending | Apr 05, 2024 |
| 18618910 | CAPTURE REAGENT FOR LATERAL FLOW IMMUNOASSAY | HOFFMAN, ALEXANDER JOSEPH | 1677 | §102§103 | Non-Final OA | — | Pending | Mar 27, 2024 |
| 18434614 | Methods, Systems, and Devices for Linear Electrowetting Cartridges | SINES, BRIAN J | 1796 | §102§103 | Non-Final OA | — | Pending | Feb 06, 2024 |
| 18427503 | Methods, Systems, and Device for Electrowetting Bar-Coded Magnetic Beads | TURK, NEIL N | 1798 | §102§103§112 | Non-Final OA | — | Pending | Jan 30, 2024 |
| 18390889 | LATERAL FLOW ANALYTICAL DEVICE AND METHOD | RAMIREZ, ALEX | 1798 | §102§103 | Non-Final OA | — | Pending | Dec 20, 2023 |
| 18391216 | PERIANAL SWAB PCR PANEL, METHODS, DEVICE, AND KITS | GOLDBERG, JEANINE ANNE | 1682 | §103 | Non-Final OA | — | Pending | Dec 20, 2023 |
| 18390970 | IMMUNOASSAY DEVICE AND METHOD | GABEL, GAILENE | 1678 | §102§112 | Non-Final OA | — | Pending | Dec 20, 2023 |
| 18541764 | DEVICES AND METHODS FOR DETECTING PANCREATIC LIPASE | DAVIS, RUTH A | 1699 | §103§112Other | Final Rejection | 70d | Pending | Dec 15, 2023 |
| 18382700 | CLINICAL DIAGNOSTIC AND PATIENT INFORMATION SYSTEMS AND METHODS | RUIZ, JOSHUA DAMIAN | 3684 | §103 | Final Rejection | — | Pending | Oct 23, 2023 |
| 18222429 | Determination of Hematocrit | MISHRA, DEEPA | 1657 | §101§103§112 | Final Rejection | 20d | Pending | Jul 15, 2023 |
| 18352792 | System and Methods for At-Home Diagnostics Utilizing Microneedles | HOEKSTRA, JEFFREY GERBEN | 3791 | §102§103 | Final Rejection | — | Pending | Jul 14, 2023 |
| 18189874 | METHODS, DEVICE, KIT AND COMPOSITIONS FOR DETECTING FELINE LUNGWORM | CHEONG, CHEOM-GIL | 1645 | §101§102§112 | Non-Final OA | — | Pending | Mar 24, 2023 |
| 17705924 | Methods for Detecting Symmetrical Dimethylarginine | EVANS, CHRISTOPHER RYAN | 1678 | §103§112 | Non-Final OA | — | Pending | Mar 28, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialIdexx Laboratories Inc. has 27 pending office actions as of October 2026, spread across 20 art units and 27 examiners.
Reginald R Reyes has the most, with 1 of Idexx Laboratories Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
